OncoSec Medical Inc. to Present at the Sachs Cancer Bio Partnering Forum and Participate in a Panel Discussion on Immunotherapies and Cancer Vaccines

Published: May 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present at the Sachs Cancer Bio Partnering Forum at the Westin Copley Place in Boston, Massachusetts, on Tuesday, May 21, at 2:05 PM ET.

Help employers find you! Check out all the jobs and post your resume.

Back to news